Shankargouda Patil

Abstract

Objective: Prospective study to evaluate the effectivity and acceptance of optical low vision aids. Materials and Methods: This is a prospective study which included 50 patients with low vision satisfying the inclusion criteria. The cases were divided in to 3 groups less than 20 years (group1), 20 to 60 years (group2) and more than 60 years (group 3). These patients were counseled and trained to us e the low vision aids in our low vision aid clinic. They were followed up for 6 months regularly and during follow up the reason for acceptance and non acceptance of these devices were found out. Results: In this study patients with better contrast sensitivity greater than or equal to 0.3 on Pelli-Robson contrast sensitivity chart had better acceptance (p value 0.0 23). Younger patients less than 20 years of age have good acceptance for both near vision aids & distance vision aids when compared to elder patients more than 60 years of age who had good acceptance for near vision aids and poor acceptance for distance vision aids (with p value of 0.001). Taking Initial best corrected visual acuity (BCVA) in to account it was seen that patients falling under economic blindness group had better acceptance (p value 0.042). Conclusion: Prescription of low vision aids (LVA), adequate training and addressing the comorbidities can improve the acceptance level. Similarly economic blindness group more readily accepted the low vision aids since it helped their academic and professional development. Patients with better contrast sensitivity had better acceptance. Addressing the expectation by proper counselling before prescripti on of low vision aids is a must. Keywords: Effectivity and acceptance of optical low vision AIDS.

Open full article page

Abstract

Introduction: This study was undertaken to compare the efficacy of topical Bromfenac 0.09% and Prednisolone 1%. Materials and Methods: This was a prospective, double blind, comparative, interventional randomized controlled trial. Total of 180 patients were included in the study. Patients were randomized into two groups. Group A received Bromfenac 0.09% BD and Group B received Prednisolone 1% QID in tapering doses along with topical antibiotics post operatively. Both the groups did not receive any topical NSAIDs preoperatively. Patients preoperative grade of cataract by LOCS III Classification, post operative anterior chamber cells by SUN classification, Intraocular pressure were recorded and compared on day 3, 15 and 45 days. Results: A total of 180 eyes were included in the study of which 20 were lost to follow up 3 in Group A and 17 in Group B. Hence a total of 160 eyes - 87 in Group A and 73 in group B completed follow up. The amount of inflammation did not differ significantly between Group A and Group B on day 3 (p=0.698) or on day 7 (p=0.325). At the end of 45 days none of the patients either in Group A or Group B had anterior chamber inflammation. IOP-There was no significant difference in IOP between the groups preoperatively (P= 0.18). But on the first follow up and subsequent follow ups there was significant difference in IOP between Group A and B (p Conclusion: Bromfenac can be used as an alternative to steroid drops in controlling post operative anterior chanber inflammation in all grades of cataract especially in steroid responders. Keywords: Bromfenac, Cataract, Inflammation, Prednisolone.

Open full article page